Liver disease and erythropoietic protoporphyria: A concise review

World Journal of Gastroenterology

Volumn 16, Issue 36, 2010, Pages 4526-4531

  Casanova González, María José ^a   Trapero Marugán, María ^a   Jones, E Anthony ^a   Moreno Otero, Ricardo ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Erythropoietic protoporphyria; Ferrochelatase; Liver; Protoporphyrin

Indexed keywords

ACETYLCYSTEINE; ACTIVATED CARBON; COLESTYRAMINE; FERROCHELATASE; HEMATIN; HEME; PROTOPORPHYRIN; URSODEOXYCHOLIC ACID;

AUTOSOMAL DOMINANT DISORDER; BONE MARROW TRANSPLANTATION; CHOLELITHIASIS; CHOLESTASIS; CLINICAL FEATURE; DIALYSIS; ENZYME DEFICIENCY; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIC PROTOPORPHYRIA; FOLLOW UP; GENE MUTATION; HEME SYNTHESIS; HEPATOBILIARY DISEASE; HUMAN; IRON THERAPY; LIVER BIOPSY; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREVALENCE; REVIEW;

EID: 77957685781     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i36.4526     Document Type: Review

References (65)

1. Magnus IA, Jarrett A, Prankerd TA, Rimington C. Erythropoietic protoporphyria. A new porphyria syndrome with solar urticaria due to protoporphyrinaemia. Lancet 1961; 2: 448-451
2. Moore MR. Biochemistry of porphyria. Int J Biochem 1993; 25: 1353-1368
3. Ventura P, Cappellini MD, Rocchi E. The acute porphyrias: a diagnostic and therapeutic challenge in internal and emergency medicine. Intern Emerg Med 2009; 4: 297-308
4. Meerman L. Erythropoietic protoporphyria. An overview with emphasis on the liver. Scand J Gastroenterol Suppl 2000; 79-85
5. Richard E, Robert-Richard E, Ged C, Moreau-Gaudry F, de Verneuil H. Erythropoietic porphyrias: animal models and update in gene-based therapies. Curr Gene Ther 2008; 8: 176-186
6. Sakaino M, Kataoka T, Taketani S. Post-transcriptional regulation of the expression of ferrochelatase by its variant mRNA. J Biochem 2009; 145: 733-738
7. Kong XF, Ye J, Gao DY, Gong QM, Zhang DH, Lu ZM, Lu YM, Zhang XX. Identification of a ferrochelatase mutation in a Chinese family with erythropoietic protoporphyria. J Hepatol 2008; 48: 375-379
8. Whatley SD, Ducamp S, Gouya L, Grandchamp B, Beaumont C, Badminton MN, Elder GH, Holme SA, Anstey AV, Parker M, Corrigall AV, Meissner PN, Hift RJ, Marsden JT, Ma Y, Mieli-Vergani G, Deybach JC, Puy H. C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. Am J Hum Genet 2008; 83: 408-414
9. Holme SA, Worwood M, Anstey AV, Elder GH, Badminton MN. Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria. Blood 2007; 110: 4108-4110
10. Tsuboi H, Yonemoto K, Katsuoka K. Erythropoietic protoporphyria with eye complications. J Dermatol 2007; 34: 790-794
11. Lecha M, Puy H, Deybach JC. Erythropoietic protoporphyria. Orphanet J Rare Dis 2009; 4: 19
12. Anstey AV, Hift RJ. Liver disease in erythropoietic protoporphyria: insights and implications for management. Gut 2007; 56: 1009-1018
13. Bruguera M, Herrero C. [Liver disease in erythropoietic protoporphyria] Gastroenterol Hepatol 2005; 28: 632-636
14. Sassa S. Modern diagnosis and management of the porphyrias. Br J Haematol 2006; 135: 281-292
15. Thunell S, Harper P, Brun A. Porphyrins, porphyrin metabolismand porphyrias. IV. Pathophysiology of erythyropoietic protoporphyria--diagnosis, care and monitoring of the patient. Scand J Clin Lab Invest 2000; 60: 581-604
16. Berroeta L, Man I, Goudie DR, Whatley SD, Elder GH, Ibbotson SH. Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members. Br J Dermatol 2007; 157: 1030-1031
17. Henderson CA, Jones S, Elder G, Ilchyshyn A. Erythropoietic protoporphyria presenting in an adult. J R Soc Med 1995; 88: 476P-477P
18. Poh-Fitzpatrick MB. Molecular and cellular mechanisms of porphyrin photosensitization. Photodermatol 1986; 3: 148-157
19. Holme SA, Anstey AV, Finlay AY, Elder GH, Badminton MN. Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life. Br J Dermatol 2006; 155: 574-581
20. Knobler E, Poh-Fitzpatrick MB, Kravetz D, Vincent WR, Muller-Eberhard U, Vincent SH. Interaction of hemopexin, albumin and liver fatty acid-binding protein with protoporphyrin. Hepatology 1989; 10: 995-997
21. Todd DJ. Gallstones in children. Am J Dis Child 1991; 145: 971-972
22. Bonkovsky HL, Schned AR. Fatal liver failure in protoporphyria. Synergism between ethanol excess and the genetic defect. Gastroenterology 1986; 90: 191-201
23. Frank M, Doss MO. Severe liver disease in protoporphyria. Curr Probl Dermatol 1991; 20: 160-167
24. Anstey AV, Hift RJ. Liver disease in erythropoietic protoporphyria: insights and implications for management. Postgrad Med J 2007; 83: 739-748
25. McGuire BM, Bloomer JR. Use of extracorporeal albumin dialysis for erythropoietic protoporphyria. Liver Transpl 2007; 13: 639-640
26. Zhang F, Lu L, Qian X, Pu LY, Li GQ, Wang XH. Liver transplantation for erythropoietic protoporphyria with hepatic failure: a case report. Transplant Proc 2008; 40: 1774-1776
27. Samuel D, Boboc B, Bernuau J, Bismuth H, Benhamou JP. Liver transplantation for protoporphyria. Evidence for the predominant role of the erythropoietic tissue in protoporphy-rin overproduction. Gastroenterology 1988; 95: 816-819
28. Polson RJ, Lim CK, Rolles K, Calne RY, Williams R. The effect of liver transplantation in a 13-year-old boy with erythropoietic protoporphyria. Transplantation 1988; 46: 386-389
29. Bloomer JR, Weimer MK, Bossenmaier IC, Snover DC, Payne WD, Ascher NL. Liver transplantation in a patient with protoporphyria. Gastroenterology 1989; 97: 188-194
30. Wagner S, Doss MO, Wittekind C, Bäcker U, Meessen D, Schmidt FW. [Erythrohepatic protoporphyria with rapidly progressing liver cirrhosis] Dtsch Med Wochenschr 1989; 114: 1837-1841
31. Mion FB, Faure JL, Berger F, McGregor B, Perrot H, Paliard P. Liver transplantation for erythropoietic protoporphyria. Report of a new case with subsequent medium-term followup. J Hepatol 1992; 16: 203-207
32. Sarkany RP, Cox TM. Autosomal recessive erythropoietic protoporphyria: a syndrome of severe photosensitivity and liver failure. QJM 1995; 88: 541-549
33. Frank M, Doss MO. [Liver cirrhosis in protoporphyria: bile acid therapy and liver transplantation] Z Gastroenterol 1995; 33: 399-403
34. Dellon ES, Szczepiorkowski ZM, Dzik WH, Graeme-Cook F, Ades A, Bloomer JR, Cosimi AB, Chung RT. Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria. Transplantation 2002; 73: 911-915
35. Do KD, Banner BF, Katz E, Szymanski IO, Bonkovsky HL. Benefits of chronic plasmapheresis and intravenous hemealbumin in erythropoietic protoporphyria after orthotopic liver transplantation. Transplantation 2002; 73: 469-472
36. Steinmüller T, Doss MO, Steffen R, Blumhardt G, Bechstein WO, Frank M, Sieg I, Kretschmar R, Neuhaus P. [Liver transplantation in erythrohepatic protoporphyria] Dtsch Med Wochenschr 1992; 117: 1097-1102
37. Lock G, Holstege A, Mueller AR, Christe W, Doss MO, Schölmerich J, Neuhaus P. Liver failure in erythropoietic protoporphyria associated with choledocholithiasis and severe post-transplantation polyneuropathy. Liver 1996; 16: 211-217
38. de Torres I, Demetris AJ, Randhawa PS. Recurrent hepatic allograft injury in erythropoietic protoporphyria. Transplantation 1996; 61: 1412-1413
39. Reichheld JH, Katz E, Banner BF, Szymanski IO, Saltzman JR, Bonkovsky HL. The value of intravenous heme-albumin and plasmapheresis in reducing postoperative complications of orthotopic liver transplantation for erythropoietic protoporphyria. Transplantation 1999; 67: 922-928
40. Meerman L, Haagsma EB, Gouw AS, Slooff MJ, Jansen PL. Long-term follow-up after liver transplantation for erythropoietic protoporphyria. Eur J Gastroenterol Hepatol 1999; 11: 431-438
41. Nguyen L, Blust M, Bailin M, Melendez L, Raines DE. Photosensitivity and perioperative polyneuropathy complicating orthotopic liver transplantation in a patient with erythropoietic protoporphyria. Anesthesiology 1999; 91: 1173-1175
42. Jiménez-Sáenz M, Caunedo-Alvarez A, Rojas M, Mata M, Villar JL, Piñar A, Herrerías-Gutiérrez J. [Severe liver failure in erythropoietic protoporphyria. A report of a case treated by liver transplantation] Med Clin (Barc) 1999; 113: 176-179
43. Sarkany RP, Norris PG. Hepatic complications of erythropoietic protoporphyria. Br J Dermatol 1994; 130: 258-259
44. Mooyaart BR, de Jong GM, van der Veen S, Driessen LH, Beukeveld GJ, Grond J, Gips CH. Hepatic disease in erythropoietic protoporphyria. Dermatologica 1986; 173: 120-130
45. McGuire BM, Bonkovsky HL, Carithers RL Jr, Chung RT, Goldstein LI, Lake JR, Lok AS, Potter CJ, Rand E, Voigt MD, Davis PR, Bloomer JR. Liver transplantation for erythropoietic protoporphyria liver disease. Liver Transpl 2005; 11: 1590-1596
46. Pirlich M, Lochs H, Schmidt HH. Liver cirrhosis in erythropoietic protoporphyria: improvement of liver function with ursodeoxycholic acid. Am J Gastroenterol 2001; 96: 3468-3469
47. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002; 36: 525-531
48. Milligan A, Graham-Brown RA, Sarkany I, Baker H. Erythropoietic protoporphyria exacerbated by oral iron therapy. Br J Dermatol 1988; 119: 63-66
49. Dobozy A, Csató M, Siklósi C, Simon N. Transfusion therapy for erythropoietic protoporphyria. Br J Dermatol 1983; 109: 571-576
50. Gordeuk VR, Brittenham GM, Hawkins CW, Mukhtar H, Bickers DR. Iron therapy for hepatic dysfunction in erythropoietic protoporphyria. Ann Intern Med 1986; 105: 27-31
51. Holme SA, Thomas CL, Whatley SD, Bentley DP, Anstey AV, Badminton MN. Symptomatic response of erythropoietic protoporphyria to iron supplementation. J Am Acad Dermatol 2007; 56: 1070-1072
52. Potter C, Tolaymat N, Bobo R, Sharp H, Rank J, Bloomer J. Hematin therapy in children with protoporphyric liver disease. J Pediatr Gastroenterol Nutr 1996; 23: 402-407
53. Tung BY, Farrell FJ, McCashland TM, Gish RG, Bacon BR, Keeffe EB, Kowdley KV. Long-term follow-up after liver transplantation in patients with hepatic iron overload. Liver Transpl Surg 1999; 5: 369-374
54. Eefsen M, Rasmussen A, Wulf HC, Brock A, Hansen BA. Erythropoietic protoporphyria and pretransplantation treatment with nonbiological liver assist devices. Liver Transpl 2007; 13: 655-657
55. McCullough AJ, Barron D, Mullen KD, Petrelli M, Park MC, Mukhtar H, Bickers DR. Fecal protoporphyrin excretion in erythropoietic protoporphyria: effect of cholestyramine and bile acid feeding. Gastroenterology 1988; 94: 177-181
56. Gorchein A, Chong SK, Mowat AP. Oral activated charcoal in protoporphyria with liver damage. Br J Clin Pharmacol 1989; 27: 703P
57. Gorchein A, Foster GR. Liver failure in protoporphyria: long-term treatment with oral charcoal. Hepatology 1999; 29: 995-996
58. Muriel P. Role of free radicals in liver diseases. Hepatol Int 2009; 3: 526-536
59. García-Monzón C, Majano PL, Zubia I, Sanz P, Apolinario A,Moreno-Otero R. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J Hepatol 2000; 32: 331-338
60. Sanz-Cameno P, Medina J, García-Buey L, García-Sánchez A, Borque MJ, Martín-Vílchez S, Gamallo C, Jones EA, Moreno-Otero R. Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J Hepatol 2002; 37: 723-729
61. Majano PL, Medina J, Zubía I, Sunyer L, Lara-Pezzi E, Maldonado-Rodríguez A, López-Cabrera M, Moreno-Otero R. N-Acetyl-cysteine modulates inducible nitric oxide synthase gene expression in human hepatocytes. J Hepatol 2004; 40: 632-637
62. Medina J, Moreno-Otero R. Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs 2005; 65: 2445-2461
63. Sperl J, Procházková J, Martásek P, Subhanová I, Franková S, Trunecka P, Jirsa M. N-acetyl cysteine averted liver transplantation in a patient with liver failure caused by erythropoietic protoporphyria. Liver Transpl 2009; 15: 352-354
64. Wahlin S, Srikanthan N, Hamre B, Harper P, Brun A. Protection from phototoxic injury during surgery and endoscopy in erythropoietic protoporphyria. Liver Transpl 2008; 14: 1340-1346
65. Meerman L, Verwer R, Slooff MJ, van Hattum J, Beukeveld GJ, Kleibeuker JH, Haagsma EB. Perioperative measures during liver transplantation for erythropoietic protoporphyria. Transplantation 1994; 57: 155-158